Tagrisso

Tagrisso Description

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma
Full Prescribing Info
Description
TAGRISSO 40 mg tablets: Each tablet contains 40 mg osimertinib (as mesylate).
TAGRISSO 80 mg tablets: Each tablet contains 80 mg osimertinib (as mesylate).
Excipients/Inactive Ingredients: Tablet core: Mannitol, Microcrystalline cellulose, Low-substituted hydroxypropyl cellulose, Sodium stearyl fumarate.
Tablet coating: Polyvinyl alcohol, Titanium dioxide (E 171), Macrogol 3350, Talc, Yellow iron oxide (E 172), Red iron oxide (E 172), Black iron oxide (E 172).
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in